Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-01-19 Stuart Bryan See Remarks Grant or award · Stock Option (right to buy) +340,000 340,000
2021-08-11 Stuart Bryan See Remarks Option exercise +28,000 $7.84 $220K 28,000
2021-08-11 Stuart Bryan See Remarks Sale −28,000 $23.75 $665K 0
2021-08-11 Stuart Bryan See Remarks Option exercise · Stock Option (right to buy) −28,000 243,571
2021-08-10 Stuart Bryan See Remarks Option exercise +32,000 $7.84 $251K 32,000
2021-08-10 Stuart Bryan See Remarks Sale −32,000 $17.50 $560K 0
2021-08-10 Stuart Bryan See Remarks Option exercise · Stock Option (right to buy) −32,000 271,571
2021-03-31 Stuart Bryan See Remarks Grant or award · Stock Option (right to buy) +350,000 350,000
2021-01-25 Stuart Bryan Chief Operating Officer Grant or award · Stock Option (right to buy) +134,376 134,376
2020-01-23 Stuart Bryan Chief Operating Officer Grant or award · Stock Option (right to buy) +105,000 105,000
2019-07-18 Stuart Bryan Chief Operating Officer Grant or award · Stock Option (right to buy) +28,571 28,571

Page 1 of 1 · 11 trades